CRISAFULLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.323
AS - Asia 954
EU - Europa 702
SA - Sud America 148
AF - Africa 22
AN - Antartide 1
Totale 3.150
Nazione #
US - Stati Uniti d'America 1.291
SG - Singapore 402
IT - Italia 283
CN - Cina 217
HK - Hong Kong 123
BR - Brasile 117
DE - Germania 91
VN - Vietnam 74
FI - Finlandia 59
FR - Francia 46
GB - Regno Unito 43
TR - Turchia 35
RU - Federazione Russa 30
UA - Ucraina 29
IE - Irlanda 24
IN - India 17
NL - Olanda 17
PL - Polonia 16
BD - Bangladesh 15
CA - Canada 13
IQ - Iraq 12
MX - Messico 12
ZA - Sudafrica 11
SE - Svezia 10
AR - Argentina 9
AT - Austria 9
ES - Italia 9
ID - Indonesia 9
JP - Giappone 9
SA - Arabia Saudita 8
MK - Macedonia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
CO - Colombia 5
EC - Ecuador 5
EG - Egitto 5
AL - Albania 4
GR - Grecia 4
LB - Libano 4
UZ - Uzbekistan 4
JM - Giamaica 3
LT - Lituania 3
PH - Filippine 3
PK - Pakistan 3
AZ - Azerbaigian 2
CH - Svizzera 2
DZ - Algeria 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 3.150
Città #
Singapore 244
Ashburn 152
San Jose 150
Hong Kong 123
Fairfield 82
Dallas 72
New York 66
The Dalles 58
Beijing 49
Munich 45
Chandler 41
Los Angeles 41
Houston 39
Helsinki 37
Princeton 34
Seattle 31
Wilmington 29
Istanbul 27
Lauterbourg 27
Milan 26
Woodbridge 26
Brescia 25
Ho Chi Minh City 25
Cambridge 24
Council Bluffs 24
Dublin 24
Jacksonville 22
Rome 22
Turku 19
Shanghai 17
Buffalo 16
San Francisco 15
Ann Arbor 14
Hanoi 13
Palermo 13
Redondo Beach 13
Warsaw 13
Denver 12
Santa Clara 12
Chicago 11
Frankfurt am Main 9
Turin 9
Atlanta 8
Moscow 8
San Diego 8
São Paulo 8
Johannesburg 7
London 7
Tianjin 7
Tokyo 7
Amsterdam 6
Des Moines 6
Poplar 6
Changsha 5
Chennai 5
Crotone 5
Haiphong 5
Nuremberg 5
Orem 5
Alexandria 4
Bergamo 4
Boardman 4
Bosio 4
Catania 4
Dosso 4
Erbil 4
Jinan 4
Kolkata 4
Manchester 4
Padova 4
Paris 4
Phoenix 4
Rio de Janeiro 4
Romola 4
Tashkent 4
Vienna 4
Belo Horizonte 3
Biên Hòa 3
Brno 3
Cape Town 3
Castelli Calepio 3
Columbus 3
Desenzano del Garda 3
Duncan 3
Florence 3
Genoa 3
Goiânia 3
Kingston 3
Lappeenranta 3
Messina 3
Montreal 3
Nanjing 3
Polska 3
Quảng Ngãi 3
Quận Phú Nhuận 3
Salvador 3
Shenyang 3
Skopje 3
Strasbourg 3
Toronto 3
Totale 1.999
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 215
SALUTE RIPRODUTTIVA NELLE PAZIENTI CON MALATTIE REUMATOLOGICHE SEGUITE PROSPETTICAMENTE DA TEAM MULTIDISCIPLINARI: ANALISI DELL’OUTCOME MATERNO-FETALE, VALUTAZIONE DELLA TERAPIA IN GRAVIDANZA E IDENTIFICAZIONE DI FATTORI DI RISCHIO PER EVENTI AVVERSI 185
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 169
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 141
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 126
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 124
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 121
Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers 114
Does seronegative obstetric APS exist? “pro” and “cons” 113
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 111
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 110
Pregnancy and reproductive aspects of systemic lupus erythematosus 102
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 100
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 100
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes 95
Managing puerperium in patients with systemic autoimmune diseases: an update 95
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 89
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 82
Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes 80
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 78
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 75
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 74
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 73
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 70
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 69
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 64
Women of childbearing age living with spondyloarthritis: time for improving knowledge and counselling about reproductive issues 63
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 61
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 60
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 59
Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome 54
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 44
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 21
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel 19
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 18
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review 15
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases 4
Totale 3.193
Categoria #
all - tutte 16.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 19 17
2021/2022167 14 23 12 7 5 13 6 8 10 20 16 33
2022/2023138 22 7 2 2 14 39 5 10 23 1 7 6
2023/2024269 19 2 23 15 7 45 13 17 52 22 12 42
2024/2025720 15 13 23 78 81 69 53 43 66 50 143 86
2025/20261.564 132 161 151 193 170 125 256 84 112 180 0 0
Totale 3.193